[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100605715":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":31,"centralContacts":35,"locations":43,"responsibleParty":65,"collaborators":67,"id":71,"slug":72,"hasResults":73,"nctId":74,"briefTitle":75,"officialTitle":75,"acronym":76,"eligibilityCriteria":77,"healthyVolunteers":73,"sex":78,"minAge":79,"maxAge":80,"enrollmentInfo":81,"targetDuration":26,"studyType":84,"phases":85,"briefSummary":87,"conditions":88,"keywords":92,"overallStatus":45,"whyStopped":26,"lastUpdateSubmitDate":96,"lastUpdatePostDateStruct":97,"startDateStruct":100,"completionDateStruct":102,"leadSponsor":104,"locationsCount":105},{"fullName":5,"class":6},"Washington University School of Medicine","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Usual Care","ACTIVE_COMPARATOR","The arm will represent usual care in the oncology care clinics. Clinicians will receive a report designed to recommend guideline-based tobacco treatment. Patients will receive a report on guideline-based advice about smoking cessation and a brief discussion with a behavior interventionist.",[13],"Behavioral: Usual care",{"label":15,"type":16,"description":17,"interventionNames":18},"PrecisionTx-Onc (oncology)","EXPERIMENTAL","Clinicians will receive PrecisionTx-Onc, an intervention designed to recommend precision tobacco treatment, adapted for oncology. Patients will receive PrecisionTx-Onc, an intervention designed to recommend precision tobacco treatment, and a brief discussion with a behavior interventionist, adapted for oncology.",[19],"Behavioral: Precision treatment",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"BEHAVIORAL","Usual care","Usual care will be informed by practice guidelines (standard of care, brief advice, and guideline awareness).",[9],null,{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"Precision treatment","Precision treatment will be informed by practice guidelines (standard of care, brief advice, and guideline awareness), plus patient-specific risk feedback and personalized tobacco treatment recommendations using patients' clinical, genetic, and biomarker information, adapted for oncology.",[15],[32],{"name":33,"affiliation":5,"role":34},"Li-Shiun Chen, ScD, M.D., MPH","PRINCIPAL_INVESTIGATOR",[36,40],{"name":33,"role":37,"phone":38,"phoneExt":26,"email":39},"CONTACT","314-362-3932","li-shiun@wustl.edu",{"name":41,"role":37,"phone":26,"phoneExt":26,"email":42},"Theodore Thomas, M.D.","thomast@wustl.edu",[44],{"facility":5,"status":45,"city":46,"state":47,"zip":48,"country":49,"countryCode":50,"cosmosGeoPoint":51,"geoPoint":56,"contacts":57},"RECRUITING","St Louis","Missouri","63110","United States","US",{"type":52,"coordinates":53},"Point",[54,55],-90.19789,38.62727,{"lat":55,"lon":54},[58,59,60,61,64],{"name":33,"role":37,"phone":38,"phoneExt":26,"email":39},{"name":41,"role":37,"phone":26,"phoneExt":26,"email":42},{"name":33,"role":34,"phone":26,"phoneExt":26,"email":26},{"name":62,"role":63,"phone":26,"phoneExt":26,"email":26},"Ramaswamy Govindan, M.D.","SUB_INVESTIGATOR",{"name":41,"role":63,"phone":26,"phoneExt":26,"email":26},{"type":66,"investigatorFullName":26,"investigatorTitle":26,"investigatorAffiliation":26,"oldNameTitle":26,"oldOrganization":26},"SPONSOR",[68],{"name":69,"class":70},"United States Department of Defense","FED","100605715","precision-treatment-to-promote-smoking-cessation-and-survival-in-oncology-patients-100605715",false,"NCT07166120","Precision Treatment to Promote Smoking Cessation and Survival in Oncology Patients","PROMISE","Eligibility Criteria for Clinicians:\n\n* Clinician from participating oncology\u002Fhematology clinic\n* At least 18 years of age\n* Can speak and understand English\n\nInclusion Criteria for Patients:\n\n* Patient at participating clinic\n* Age 18-89 years\n* Current smoking (average cigarettes per day ≥5)\n* Can speak and understand English\n* Willing to consider medication to help reduce craving or smoking such as nicotine patch, lozenge, or varenicline\n\nExclusion Criteria for Patients:\n\n* Active use of smoking cessation medication (within the past 30 days)\n* Receipt of smoking cessation medication or prescription for smoking cessation medication (within the past 30 days)\n* Having a contradiction for cNRT or varenicline (allergic reactions, current cardiac problems, pregnancy)\n* Patients who were deemed by the investigator to be ineligible for participation in the trial","ALL","18 Years","89 Years",{"count":82,"type":83},112,"ESTIMATED","INTERVENTIONAL",[86],"NA","This study evaluates the feasibility and preliminary effects of precision tobacco treatment, compared to usual care, on promoting tobacco treatment in oncology patients and providers in the oncology care setting. The precision treatment intervention includes personalized tobacco treatment recommendations using the patient's clinical, genetic, and biomarker information. This intervention may increase patient receipt of tobacco treatment, patient medication use, and patient smoking abstinence at 6 months.",[89,90,91],"Smoking Cessation","Smoking","Physician's Role",[93,94,95],"Genetics","Primary Care Physicians","Tobacco Treatment","2025-10-28",{"date":98,"type":99},"2025-10-30","ACTUAL",{"date":101,"type":99},"2025-09-11",{"date":103,"type":83},"2027-09-30",{"name":5,"class":6},1]